Yasmin Nouri

587 total citations
6 papers, 79 citations indexed

About

Yasmin Nouri is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Yasmin Nouri has authored 6 papers receiving a total of 79 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Immunology. Recurrent topics in Yasmin Nouri's work include CAR-T cell therapy research (2 papers), Glycosylation and Glycoproteins Research (1 paper) and Mast cells and histamine (1 paper). Yasmin Nouri is often cited by papers focused on CAR-T cell therapy research (2 papers), Glycosylation and Glycoproteins Research (1 paper) and Mast cells and histamine (1 paper). Yasmin Nouri collaborates with scholars based in New Zealand, Australia and China. Yasmin Nouri's co-authors include Robert Weinkove, Rachel Perret, Parry Guilford, Nicola Bougen‐Zhukov, Tom P. Brew, Tanis Godwin, Michael A. Black, Augustine Chen, Andrew Single and Alexander J. Davenport and has published in prestigious journals such as Blood, Cancers and Journal for ImmunoTherapy of Cancer.

In The Last Decade

Yasmin Nouri

6 papers receiving 78 citations

Peers

Yasmin Nouri

MB

IMMUN

ONCOL

PFM

PRM

Santiago Sánchez‐Alonso Spain

Julia Han Noll Germany

Nicholas Ang United States

Sonia Aristín Revilla Netherlands

Jöran Lücke Germany

Anghesom Ghebremedhin United States

Caroline Ang Australia

Miguel Caballero‐Baños Spain

Savithri B. Kota United States

Santiago Sánchez‐Alonso Spain

Yasmin Nouri

32 ×0.9

MB

45 ×1.3

IMMUN

41 ×1.6

ONCOL

8 ×0.8

PFM

6 ×0.6

PRM

Citations per year, relative to Yasmin Nouri Yasmin Nouri (= 1×) peers Santiago Sánchez‐Alonso

Countries citing papers authored by Yasmin Nouri

Since Specialization

Citations

This map shows the geographic impact of Yasmin Nouri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasmin Nouri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasmin Nouri more than expected).

Fields of papers citing papers by Yasmin Nouri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasmin Nouri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasmin Nouri. The network helps show where Yasmin Nouri may publish in the future.

Co-authorship network of co-authors of Yasmin Nouri

This figure shows the co-authorship network connecting the top 25 collaborators of Yasmin Nouri. A scholar is included among the top collaborators of Yasmin Nouri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasmin Nouri. Yasmin Nouri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Nouri, Yasmin, Nancy Dalton, Stacie Shiqi Wang, et al.. (2025). Defining the extracellular matrix for targeted immunotherapy in adult and pediatric brain cancer. npj Precision Oncology. 9(1). 184–184. 2 indexed citations

2.

Nouri, Yasmin, Robert Weinkove, & Rachel Perret. (2023). An In Vitro Model to Assess CRS Potential of CAR T Cells Using a Tumor Cell Line and Autologous Monocytes. Current Protocols. 3(8). e864–e864. 4 indexed citations

3.

Weinkove, Robert, P J George, Nathaniel Dasyam, et al.. (2023). A Phase 1 Dose Escalation Trial of Third-Generation CD19-Directed CAR T-Cells Incorporating CD28 and Toll-like Receptor 2 (TLR2) Intracellular Domains for Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas (ENABLE). Blood. 142(Supplement 1). 890–890. 4 indexed citations

4.

Brew, Tom P., et al.. (2021). Loss of E-Cadherin Leads to Druggable Vulnerabilities in Sphingolipid Metabolism and Vesicle Trafficking. Cancers. 14(1). 102–102. 7 indexed citations

5.

Nouri, Yasmin, Robert Weinkove, & Rachel Perret. (2021). T-cell intrinsic Toll-like receptor signaling: implications for cancer immunotherapy and CAR T-cells. Journal for ImmunoTherapy of Cancer. 9(11). e003065–e003065. 40 indexed citations

6.

Bougen‐Zhukov, Nicola, Yasmin Nouri, Tanis Godwin, et al.. (2019). Allosteric AKT Inhibitors Target Synthetic Lethal Vulnerabilities in E-Cadherin-Deficient Cells. Cancers. 11(9). 1359–1359. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact